Purchases and Sales Made in Q2 2023 in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE) during Q2 2023. The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 26, 2024
Q2 2023
|
Erste Asset Management Gmb H
Vienna, C4 |
SELL
|
- |
-1.56MClosed |
$0 - $3.03M
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-2.21M- 76.74% |
$0 - $4.29M
|
670K
$0
|